智通财经网·2025-09-19 07:37Group 1 - The core viewpoint of the article is that the prescription drug sector is driving accelerated growth in online pharmacy revenues in China this year [1] - JD Health (06618) projects a year-on-year revenue growth of approximately 20% and an adjusted net profit growth of 15% for this year [1] - Alibaba Health (00241) forecasts a year-on-year revenue growth of 10% to 15% and an adjusted net profit growth of 20% to 30% for the fiscal year ending March 2026 [1] Group 2 - The report indicates that strong sales of original manufacturer drugs in the second half of the year suggest potential upward pressure on profitability [1] - Despite high online penetration rates in most retail categories, the pharmaceutical sector has the greatest growth potential online [1]